- Home
- NAUT vs MLCI Comparison
NAUT vs MLCI Comparison
Compare NAUT & MLCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAUT
- MLCI
- Stock Information
- Founded
- NAUT 2016
- MLCI N/A
- Country
- NAUT United States
- MLCI United States
- Employees
- NAUT N/A
- MLCI N/A
- Industry
- NAUT Biotechnology: Laboratory Analytical Instruments
- MLCI Investment Managers
- Sector
- NAUT Industrials
- MLCI Finance
- Exchange
- NAUT Nasdaq
- MLCI Nasdaq
- Market Cap
- NAUT 104.7M
- MLCI 98.0M
- IPO Year
- NAUT N/A
- MLCI N/A
- Fundamental
- Price
- NAUT $1.82
- MLCI $7.85
- Analyst Decision
- NAUT Strong Sell
- MLCI
- Analyst Count
- NAUT 1
- MLCI 0
- Target Price
- NAUT $1.75
- MLCI N/A
- AVG Volume (30 Days)
- NAUT 790.4K
- MLCI 41.6K
- Earning Date
- NAUT 10-28-2025
- MLCI 01-01-0001
- Dividend Yield
- NAUT N/A
- MLCI 3.07%
- EPS Growth
- NAUT N/A
- MLCI N/A
- EPS
- NAUT N/A
- MLCI N/A
- Revenue
- NAUT N/A
- MLCI $99,281,000.00
- Revenue This Year
- NAUT N/A
- MLCI N/A
- Revenue Next Year
- NAUT N/A
- MLCI N/A
- P/E Ratio
- NAUT N/A
- MLCI N/A
- Revenue Growth
- NAUT N/A
- MLCI N/A
- 52 Week Low
- NAUT $0.62
- MLCI $4.60
- 52 Week High
- NAUT $2.51
- MLCI $8.75
- Technical
- Relative Strength Index (RSI)
- NAUT 64.84
- MLCI N/A
- Support Level
- NAUT $1.60
- MLCI N/A
- Resistance Level
- NAUT $1.91
- MLCI N/A
- Average True Range (ATR)
- NAUT 0.21
- MLCI 0.00
- MACD
- NAUT 0.02
- MLCI 0.00
- Stochastic Oscillator
- NAUT 84.13
- MLCI 0.00
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
About MLCI Mount Logan Capital Inc. Common Stock
Mount Logan Capital Inc operates as emerging asset management and investment firm focused on investing in public and private debt securities in the North American market. The Company's reporting segments include asset management and insurance. The asset management segment reflects the Company's historical operations through its subsidiaries, including ML Management, and the insurance segment represents Ability's operations. The Company through its subsidiaries, earns management and incentive fees and servicing fees for providing investment management, monitoring and other services to investment vehicles and advisers. The insurance business is operated by Ability. Ability's insurance business consists of premium revenue from long term care insurance policies.